Overall, Amazon's revenue rose by 13% year over year to $180.2 billion, which came in above the $177.8 billion analyst consensus, as compiled by LSEG. Earnings per share climbed 36% to $1.95, which ...

CFO Bellet reported that input cost and inflation are now projected to increase about $70 million for the full year, "about $20 million more favorable" than prior estimates, while tariffs remain a $40 ...

Ambition to scale has never been higher, and tensions over workplace culture, talent retention, process efficiency and authentic integration have never been more intense.

L'Oreal Chairman Jean-Paul Agon appears for an event at the 7th China International Import Expo. [Photo provided to chinadaily.com.cn] Jean-Paul Agon, chairman of the L'Oreal Group, detailed the ...

Switzerland’s government cut its growth forecast for next year, acknowledging that US tariffs will cause sizable damage to the economy. Gross domestic product will grow just 0.9% in 2026, the State ...

Gambling content 21+. The New York Post may receive an affiliate commission if you sign up through our links. Read our editorial standards for more information. Everyone had the Packers last week and ...

The pecking order of the 2026 NFL Draft quarterback prospects has been fluid this season. The rankings look a lot different now than it had when the season began and will continue to evolve over the ...

Miriam Adelson was namechecked by Donald Trump at the Knesset, the Israeli parliament, in a shoutout to the Republican megadonor who has been central to the U.S. president’s Israel policy. Trump told ...

If you graph the history of economic growth, it looks a lot like a hockey stick laid on the ground with its blade sticking up. That is, economic growth was pretty flat for millennia, and then, around ...

Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” third-quarter 2025 investor letter. The equity market continued its strong performance in the third quarter ...

RESEARCH TRIANGLE PARK, N.C., & BOSTON--(BUSINESS WIRE)--BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) and Astria Therapeutics, Inc. (Nasdaq: ATXS) today announced that the companies have entered into ...

BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) and Astria Therapeutics, Inc. (Nasdaq: ATXS) today announced that the companies have entered into a definitive agreement under which BioCryst has agreed ...